• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未来流感大流行的疫苗接种策略:基于严重程度的成本效益分析。

Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.

机构信息

School of Computer Science and Software Engineering, University of Western Australia, Stirling Highway, Crawley, Western Australia 6009, Australia.

出版信息

BMC Infect Dis. 2013 Feb 11;13:81. doi: 10.1186/1471-2334-13-81.

DOI:10.1186/1471-2334-13-81
PMID:23398722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3637125/
Abstract

BACKGROUND

A critical issue in planning pandemic influenza mitigation strategies is the delay between the arrival of the pandemic in a community and the availability of an effective vaccine. The likely scenario, born out in the 2009 pandemic, is that a newly emerged influenza pandemic will have spread to most parts of the world before a vaccine matched to the pandemic strain is produced. For a severe pandemic, additional rapidly activated intervention measures will be required if high mortality rates are to be avoided.

METHODS

A simulation modelling study was conducted to examine the effectiveness and cost effectiveness of plausible combinations of social distancing, antiviral and vaccination interventions, assuming a delay of 6-months between arrival of an influenza pandemic and first availability of a vaccine. Three different pandemic scenarios were examined; mild, moderate and extreme, based on estimates of transmissibility and pathogenicity of the 2009, 1957 and 1918 influenza pandemics respectively. A range of different durations of social distancing were examined, and the sensitivity of the results to variation in the vaccination delay, ranging from 2 to 6 months, was analysed.

RESULTS

Vaccination-only strategies were not cost effective for any pandemic scenario, saving few lives and incurring substantial vaccination costs. Vaccination coupled with long duration social distancing, antiviral treatment and antiviral prophylaxis was cost effective for moderate pandemics and extreme pandemics, where it saved lives while simultaneously reducing the total pandemic cost. Combined social distancing and antiviral interventions without vaccination were significantly less effective, since without vaccination a resurgence in case numbers occurred as soon as social distancing interventions were relaxed. When social distancing interventions were continued until at least the start of the vaccination campaign, attack rates and total costs were significantly lower, and increased rates of vaccination further improved effectiveness and cost effectiveness.

CONCLUSIONS

The effectiveness and cost effectiveness consequences of the time-critical interplay of pandemic dynamics, vaccine availability and intervention timing has been quantified. For moderate and extreme pandemics, vaccination combined with rapidly activated antiviral and social distancing interventions of sufficient duration is cost effective from the perspective of life years saved.

摘要

背景

规划大流行性流感缓解策略的一个关键问题是大流行在社区出现与有效疫苗可用之间的延迟。在 2009 年大流行中已经出现的可能情况是,一种新出现的流感大流行将在生产出与大流行株匹配的疫苗之前传播到世界大部分地区。对于严重的大流行,如果要避免高死亡率,则需要采取其他快速激活的干预措施。

方法

进行了一项模拟模型研究,以检查在假设流感大流行到达后 6 个月才首次提供疫苗的情况下,社会隔离、抗病毒和疫苗接种干预措施的合理组合的有效性和成本效益。根据对 2009 年、1957 年和 1918 年流感大流行的传染性和致病性的估计,研究了三种不同的大流行情况;轻度、中度和重度。考察了不同持续时间的社会隔离措施,并分析了疫苗接种延迟变化(范围为 2 至 6 个月)对结果的敏感性。

结果

对于任何大流行情况,仅接种疫苗的策略都不具有成本效益,因为它节省的生命很少,并且会产生大量的疫苗接种成本。在中度和重度大流行中,接种疫苗加上长时间的社会隔离、抗病毒治疗和抗病毒预防是具有成本效益的,因为它可以挽救生命,同时降低总大流行成本。没有接种疫苗的联合社会隔离和抗病毒干预措施效果显著降低,因为一旦放松社会隔离干预措施,病例数就会再次增加。如果继续实施社会隔离干预措施,直到至少开始疫苗接种运动,那么发病和总成本将显著降低,并且增加疫苗接种率将进一步提高有效性和成本效益。

结论

已经量化了大流行动态、疫苗供应和干预时机之间的时间关键相互作用的效果和成本效益后果。对于中度和重度大流行,接种疫苗结合快速激活的抗病毒和足够持续时间的社会隔离干预措施从挽救生命的角度来看是具有成本效益的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/4fed16fc0ed9/1471-2334-13-81-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/1d61f4797c09/1471-2334-13-81-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/a55f477b76fa/1471-2334-13-81-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/c9ebbe911606/1471-2334-13-81-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/4fed16fc0ed9/1471-2334-13-81-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/1d61f4797c09/1471-2334-13-81-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/a55f477b76fa/1471-2334-13-81-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/c9ebbe911606/1471-2334-13-81-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8db1/3637125/4fed16fc0ed9/1471-2334-13-81-4.jpg

相似文献

1
Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.未来流感大流行的疫苗接种策略:基于严重程度的成本效益分析。
BMC Infect Dis. 2013 Feb 11;13:81. doi: 10.1186/1471-2334-13-81.
2
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.基于模型的大流行前流感疫苗接种成本效益经济分析。
BMC Infect Dis. 2014 May 16;14:266. doi: 10.1186/1471-2334-14-266.
3
The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.大流行性流感干预措施的成本效益:基于大流行严重程度的分析。
PLoS One. 2013 Apr 9;8(4):e61504. doi: 10.1371/journal.pone.0061504. Print 2013.
4
Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.欧洲国家大流行性流感疫苗接种的成本效益:数学模型分析。
BMJ. 2012 Jul 12;345:e4445. doi: 10.1136/bmj.e4445.
5
Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?在严重疫情期间,非正式社交距离干预措施能否将对抗病毒治疗的需求降至最低?
BMC Public Health. 2013 Jul 18;13:669. doi: 10.1186/1471-2458-13-669.
6
Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.2009 年甲型 H1N1 流感大流行疫苗接种在美国的成本效益分析。
PLoS One. 2011;6(7):e22308. doi: 10.1371/journal.pone.0022308. Epub 2011 Jul 29.
7
Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions.芝加哥大流行性流感的流行病学和经济影响:疫苗干预的优先事项。
PLoS Comput Biol. 2017 Jun 1;13(6):e1005521. doi: 10.1371/journal.pcbi.1005521. eCollection 2017 Jun.
8
Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies.基于药物的大流行性流感缓解策略的成本效益。
Emerg Infect Dis. 2010 Feb;16(2):224-30. doi: 10.3201/eid1602.090571.
9
Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions.甲型H1N1流感的性价比:大流行干预措施成本效益的系统评价
Value Health. 2017 Jun;20(6):819-827. doi: 10.1016/j.jval.2016.05.005. Epub 2016 Jun 29.
10
Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.甲型 H5N1 流感大流行中扩大抗病毒预防和佐剂疫苗接种策略的效果和成本效益。
Ann Intern Med. 2009 Dec 15;151(12):840-53. doi: 10.7326/0003-4819-151-12-200912150-00156.

引用本文的文献

1
Economic Impacts of Initiating Vaccination at 3 Months vs. 6 Months in an Influenza Pandemic in the United States.美国流感大流行期间3个月龄与6个月龄开始接种疫苗的经济影响。
Vaccines (Basel). 2025 Aug 1;13(8):828. doi: 10.3390/vaccines13080828.
2
Place of distancing measures in containing epidemics: a scoping review.疫情防控中隔离措施的实施地点:范围综述。
Libyan J Med. 2022 Dec;17(1):2140473. doi: 10.1080/19932820.2022.2140473.
3
Qinbaohong Zhike Oral Liquid Attenuates LPS-Induced Acute Lung Injury in Immature Rats by Inhibiting OLFM4.

本文引用的文献

1
Updating Australia's pandemic preparedness: the revised Australian Health Management Plan for Pandemic Influenza (AHMPPI).更新澳大利亚的大流行防范能力:修订后的《澳大利亚大流行性流感健康管理计划》(AHMPPI)。
J Law Med. 2015 Mar;22(3):506-11.
2
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study.估算与 2009 年甲型 H1N1 流感病毒流行的头 12 个月相关的全球死亡人数:一项建模研究。
Lancet Infect Dis. 2012 Sep;12(9):687-95. doi: 10.1016/S1473-3099(12)70121-4. Epub 2012 Jun 26.
3
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host.
芩暴红止咳口服液通过抑制 OLFM4 减轻 LPS 诱导的幼鼠急性肺损伤
Oxid Med Cell Longev. 2022 Aug 16;2022:7272371. doi: 10.1155/2022/7272371. eCollection 2022.
4
Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.通过非药物干预和为儿童接种疫苗来减轻澳大利亚的 SARS-CoV-2 Delta 疾病负担:建模分析。
BMC Med. 2022 Feb 18;20(1):80. doi: 10.1186/s12916-022-02241-3.
5
A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia.澳大利亚第二波 COVID-19 应对策略效果的建模分析。
Sci Rep. 2021 Jun 7;11(1):11958. doi: 10.1038/s41598-021-91418-6.
6
Herbal Medication to Enhance or Modulate Viral Infections.草药药物增强或调节病毒感染。
Nurs Clin North Am. 2021 Mar;56(1):79-89. doi: 10.1016/j.cnur.2020.10.007. Epub 2020 Nov 28.
7
How resource limitations and household economics may compromise efforts to safeguard children during outbreaks.资源限制和家庭经济状况如何影响在疫情期间保护儿童的努力。
BMC Public Health. 2020 Feb 24;20(1):270. doi: 10.1186/s12889-019-7968-6.
8
Evaluation of Influenza Intervention Strategies in Turkey with Fuzzy AHP-VIKOR.基于模糊层次分析法-逼近理想解排序法(FAHP-VIKOR)评价土耳其的流感干预策略
J Healthc Eng. 2019 Nov 19;2019:9486070. doi: 10.1155/2019/9486070. eCollection 2019.
9
Medical Outcomes in Women Who Became Pregnant after Vaccination with a Virus-Like Particle Experimental Vaccine against Influenza A (H1N1) 2009 Virus Tested during 2009 Pandemic Outbreak.2009 年大流行期间试验的针对甲型流感(H1N1)2009 病毒的病毒样颗粒实验疫苗接种后怀孕的女性的医学结局。
Viruses. 2019 Sep 17;11(9):868. doi: 10.3390/v11090868.
10
Regulation of influenza virus replication by Wnt/β-catenin signaling.Wnt/β-连环蛋白信号通路对流感病毒复制的调控
PLoS One. 2018 Jan 11;13(1):e0191010. doi: 10.1371/journal.pone.0191010. eCollection 2018.
A/H5N1 流感病毒在哺乳动物宿主体内进化为呼吸道飞沫传播的潜力。
Science. 2012 Jun 22;336(6088):1541-7. doi: 10.1126/science.1222526.
4
Airborne transmission of influenza A/H5N1 virus between ferrets.雪貂之间甲型流感病毒 H5N1 的空气传播。
Science. 2012 Jun 22;336(6088):1534-41. doi: 10.1126/science.1213362.
5
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.实验性改造的流感 H5 HA 可使重组 H5 HA/H1N1 病毒在雪貂中通过呼吸道飞沫传播。
Nature. 2012 May 2;486(7403):420-8. doi: 10.1038/nature10831.
6
Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.2009 年甲型 H1N1 流感大流行期间挪威疫苗和抗病毒药物的效果——以及接种时间的影响。
PLoS One. 2012;7(1):e30018. doi: 10.1371/journal.pone.0030018. Epub 2012 Jan 10.
7
Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything.在加拿大温哥华的人口动力学模型中对 2009 年大流行 H1N1 的疫苗接种:时机就是一切。
BMC Public Health. 2011 Dec 14;11:932. doi: 10.1186/1471-2458-11-932.
8
Influenza.
Nature. 2011 Dec 7;480(7376):S1. doi: 10.1038/480S1a.
9
Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.2009 年甲型 H1N1 流感大流行疫苗接种在美国的成本效益分析。
PLoS One. 2011;6(7):e22308. doi: 10.1371/journal.pone.0022308. Epub 2011 Jul 29.
10
Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics.具有 H1N1 2009 特征的未来流感大流行的成本效益缓解策略。
PLoS One. 2011;6(7):e22087. doi: 10.1371/journal.pone.0022087. Epub 2011 Jul 8.